Proven Results in
Clinical Trials

Click on a topic to get more information

See how ORIAHNN was studied in women like you

See how ORIAHNN was studied in women like you

The 790 women who participated in the ORIAHNN clinical trials (all with heavy periods due to fibroids) are as unique as you. These women represent a range of characteristics:

Woman Icon.

Race included
68% Black/African American
29% White/Caucasian
3% Other races/ethnicities

Uterus Icon.

Fibroids varied
in both size
and location

Icon depicting reduced menstrual bleeding.

Bleeding per period at the
start of the trials ranged
from 1/3 of a cup to 5 cups

Icon depicting age of women ranged from 25 to 53 years old.

Age ranged from
25 to 53 years old

Weight Scale Icon.

Weight ranged from
108 lbs to 355 lbs

Icon depicts women with and without children.

Trials included
women with and without children

ORIAHNN clinical trial results

ORIAHNN was studied in two 6-month clinical trials, including premenopausal women aged 25-53 with heavy periods due to uterine fibroids.

ORIAHNN was proven to lighten heavy periods in about

7 in 10 women*

This meant bleeding volume was reduced by at least 50% from the start of trial, and to below 80 mL
(about 1/3 of a cup) at the final month of treatment.

This meant bleeding volume was reduced by at least 50% from the start of trial, and to below 80 mL (about 1/3 of a cup) at the final month of treatment.

*Compared with about 1 in 10 women taking placebo.

Average bleeding was reduced by 89% (-188 mL)

Measuring cup depicting that the average menstrual bleeding while taking ORIAHNN® was reduced by about 89%.

ORIAHNN values from the start of Trial 2 to Month 6 compared with an increase of about 9% (12 mL) in women taking placebo.

For the start of Trial 1 to Month 6, average bleeding was reduced by about 81% (189 mL) compared with an average decrease of about 3% (9 mL) in women taking placebo.

Average bleeding was reduced quickly
by half at Month 1 and about 85% at Month 3


Measuring cup depicting the amount of menstrual bleeding at the start of the ORIAHNN® clinical trial.
Start of Trial

228 mL

Measuring cup depicting menstrual bleeding after month 1 of the ORIAHNN® clinical trial.
Month 1

-122 mL

51%
Measuring cup depicting menstrual bleeding after month 3 of the ORIAHNN® clinical trial.
Month 3

-194 mL

86%
Measuring cup depicting menstrual bleeding after month 6 of the ORIAHNN® clinical trial.
Month 6

-188 mL

89%

ORIAHNN values for Trial 2. Placebo values were 256 mL at start of trial and resulted in 6% (16 mL) average decrease at Month 1, 12% (27 mL) average decrease at Month 3, and 9% (12 mL) average increase at Month 6.

For Trial 1, ORIAHNN values were 238 mL at start of trial, and resulted in a 52% (124 mL) average decrease at Month 1, 82% (187 mL) average decrease at Month 3, and 81% (189 mL) average decrease at Month 6. Placebo values were 259 mL at start of trial and resulted in 13% (33 mL) average decrease at Month 1, 4% (0.1 mL) average decrease at Month 3, and 3% (9 mL) average decrease at Month 6.

Most women taking ORIAHNN were able to control their heavy menstrual bleeding without surgery§

  • During the 6-month clinical trials, 3 women out of 395 required surgery for their uterine fibroids

§Most women were eligible for surgery.

Hear about the broad range of women in the clinical trials and their results

Question Icon.

Got questions? We've got answers.

 

Have questions about ORIAHNN?

We’re just a phone call away Monday through Friday, 8AM-8PM ET.

(1-800-674-2466)

Woman discussing with her gynecologist

How Do Heavy Periods Affect You?

Better understand your heavy periods and when to talk to your gynecologist.

Take quiz
ORIAHNN™ Patient Julie

Real Moments with ORIAHNN

Learn how Julie took control over her heavy periods.

Watch Julie's story
Woman in bed with her partner and children

Taking ORIAHNN

Find out how to take ORIAHNN, and what to do if you miss a pill.

Get info